Page last updated: 2024-10-18

glycine and Hemorrhage

glycine has been researched along with Hemorrhage in 46 studies

Hemorrhage: Bleeding or escape of blood from a vessel.

Research Excerpts

ExcerptRelevanceReference
"The first clinical studies evaluating the safety and efficacy of melagatran, a novel, direct thrombin inhibitor, given subcutaneously as prophylaxis for venous thromboembolism (VTE) following total hip (THR) or total knee replacement (TKR) are reported."9.10Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies. ( Ahnfelt, L; Arfwidsson, AC; Björkström, S; Elvander, CS; Eriksson, BI; Eriksson, UG; Folestad, A; Frison, L; Kälebo, P; Ogren, M; Sjöstedt, A, 2002)
"The antithrombotic and bleeding properties of the oral direct thrombin inhibitor ximelagatran and of warfarin were investigated in an experimental venous thrombosis and bleeding model in anaesthetized rats."7.73The effects of ximelagatran and warfarin on the prophylaxis of a caval vein thrombosis and bleeding in the anaesthetized rat. ( Carlsson, S; Elg, M, 2005)
" The purpose of this study was to use a rabbit arterial thrombosis prevention and ear bleeding model to determine whether for equivalent efficacy, melagatran, a synthetic direct thrombin inhibitor, is safer than hirudin."7.72The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model. ( Carlsson, S; Johnston, M; Klement, P; Liao, P; Rak, J; Stafford, A; Vlasin, M; Weitz, JI, 2003)
"Melagatran 2 mg was started immediately before surgery; 3 mg was then administered postoperatively, followed by 24 mg of oral ximelagatran b."6.71The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. ( Agnelli, G; Andersson, M; Cohen, AT; Dahl, OE; Eriksson, BI; Eskilson, C; Freij, A; Kälebo, P; Lassen, MR; Mouret, P; Panfilov, S; Rosencher, N, 2003)
"The pharmacokinetic dose linearity and reproducibility, the effects on ex-vivo coagulation time assays and bleeding time, and tolerability of the direct thrombin inhibitor melagatran following subcutaneous (s."5.10Pharmacokinetics and anticoagulant effect of the direct thrombin inhibitor melagatran following subcutaneous administration to healthy young men. ( Eriksson, UG; Johansson, S; Larson, G; Larsson, M; Ohlsson, L; Wåhlander, K, 2003)
"The first clinical studies evaluating the safety and efficacy of melagatran, a novel, direct thrombin inhibitor, given subcutaneously as prophylaxis for venous thromboembolism (VTE) following total hip (THR) or total knee replacement (TKR) are reported."5.10Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies. ( Ahnfelt, L; Arfwidsson, AC; Björkström, S; Elvander, CS; Eriksson, BI; Eriksson, UG; Folestad, A; Frison, L; Kälebo, P; Ogren, M; Sjöstedt, A, 2002)
" Herein, inspired by fibrinogen binding to activated platelets in thrombosis, this article reports a fibrinogen-mimicking, activated-platelet-sensitive nanocoacervate to enhance thrombus penetration of tissue plasminogen activator (tPA) for targeted thrombolytic therapy."4.12A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy. ( Chen, R; Guo, Y; Huang, Y; Jiang, J; Li, Y; Ren, J; Zhao, Q; Zhou, J, 2022)
"The antithrombotic and bleeding properties of the oral direct thrombin inhibitor ximelagatran and of warfarin were investigated in an experimental venous thrombosis and bleeding model in anaesthetized rats."3.73The effects of ximelagatran and warfarin on the prophylaxis of a caval vein thrombosis and bleeding in the anaesthetized rat. ( Carlsson, S; Elg, M, 2005)
" The purpose of this study was to use a rabbit arterial thrombosis prevention and ear bleeding model to determine whether for equivalent efficacy, melagatran, a synthetic direct thrombin inhibitor, is safer than hirudin."3.72The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model. ( Carlsson, S; Johnston, M; Klement, P; Liao, P; Rak, J; Stafford, A; Vlasin, M; Weitz, JI, 2003)
"Ximelagatran was to be initiated within the first two postoperative days."2.71Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. ( Agnelli, G; Cohen, AT; Dahl, OE; Eriksson, BI; Eskilson, C; Frison, L; Mouret, P; Nylander, I; Ogren, M; Rosencher, N, 2003)
"Melagatran 2 mg was started immediately before surgery; 3 mg was then administered postoperatively, followed by 24 mg of oral ximelagatran b."2.71The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. ( Agnelli, G; Andersson, M; Cohen, AT; Dahl, OE; Eriksson, BI; Eskilson, C; Freij, A; Kälebo, P; Lassen, MR; Mouret, P; Panfilov, S; Rosencher, N, 2003)
"Glyphosate is an organophosphorus compound and the active ingredient in commonly used herbicides, whereas polyoxyethyleneamine (POEA) is a nonionic surfactant often coupled with glyphosate in these herbicides to increase their efficacy."1.62Glyphosate and Polyoxyethyleneamine Ingestion Leading to Renal, Hepatic, and Pulmonary Failure. ( Bigner, JA; Burney, HE; Fiester, SE; Fulcher, JW; Schammel, CMG; Teuber, JM; Ward, ME; Wheeler, JF; Wheeler, SK, 2021)
"This glycine was located in strand 5B and was well conserved in other serpins."1.46Mutation in a highly conserved glycine residue in strand 5B of plasminogen activator inhibitor 1 causes polymerisation. ( Iwaki, T; Kanayama, N; Nagahashi, K; Suzuki-Inoue, K; Takano, K; Umemura, K; Urano, T, 2017)
"When bleeding was repeated after 10 min (B2), arterial pressure dropped promptly, and plasma AVP, ANG II, osmolality and glucose augmented remarkably."1.33Anteroventral third ventricular N-methyl-D-aspartate receptors, but not metabotropic glutamate receptors are involved in hemorrhagic AVP secretion. ( Watanabe, K; Yamaguchi, K, 2005)
"Platelet-type von Willebrand disease (plt-VWD) is a congenital bleeding disorder characterized by gain-of-function mutations of GPIbalpha."1.32Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease. ( Ikeda, Y; Matsubara, Y; Murata, M; Sugita, K, 2003)
"Lung hemorrhage was seen in the animals with pancreatitis untreated with ONO-5046 24 hr following the first cerulein injection."1.29Neutrophil elastase inhibitor (ONO-5046) prevents lung hemorrhage induced by lipopolysaccharide in rat model of cerulein pancreatitis. ( Guo, L; Ikei, S; Ogawa, M; Sugita, H; Yamaguchi, Y, 1995)

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-199019 (41.30)18.7374
1990's5 (10.87)18.2507
2000's15 (32.61)29.6817
2010's5 (10.87)24.3611
2020's2 (4.35)2.80

Authors

AuthorsStudies
Huang, Y1
Jiang, J1
Ren, J1
Guo, Y1
Zhao, Q1
Zhou, J1
Li, Y1
Chen, R1
Bigner, JA1
Fiester, SE1
Fulcher, JW1
Schammel, CMG1
Ward, ME1
Burney, HE1
Wheeler, JF1
Wheeler, SK1
Teuber, JM1
Capmas, P1
Levaillant, JM1
Fernandez, H1
Lu, Q1
Yang, L1
Manithody, C1
Wang, X1
Rezaie, AR1
Iwaki, T1
Nagahashi, K1
Takano, K1
Suzuki-Inoue, K1
Kanayama, N1
Umemura, K1
Urano, T1
Yokoyama, T1
Tsushima, K1
Ushiki, A1
Kobayashi, N1
Urushihata, K1
Koizumi, T1
Kubo, K1
Sribanditmongkol, P1
Jutavijittum, P1
Pongraveevongsa, P1
Wunnapuk, K1
Durongkadech, P1
Eriksson, BI3
Agnelli, G2
Cohen, AT2
Dahl, OE2
Mouret, P2
Rosencher, N2
Eskilson, C2
Nylander, I1
Frison, L2
Ogren, M2
Klement, P1
Carlsson, S3
Rak, J1
Liao, P1
Vlasin, M1
Stafford, A1
Johnston, M1
Weitz, JI1
ANTUZZI, P1
KILPI, S1
VIIKARI, SJ1
JAAKKOLA, S1
MULFORD, DJ1
GRAY, CH1
SCOTT, JJ1
AOKI, K1
MILANI, L1
Johansson, S1
Wåhlander, K1
Larson, G1
Ohlsson, L1
Larsson, M1
Eriksson, UG2
Matsubara, Y1
Murata, M1
Sugita, K1
Ikeda, Y1
Lassen, MR1
Kälebo, P2
Panfilov, S1
Andersson, M1
Freij, A1
Levi, M1
Bijsterveld, NR1
Keller, TT1
Hagio, T2
Matsumoto, S2
Nakao, S2
Abiru, T1
Ohno, H1
Kawabata, K3
Matsuoka, S1
Elg, M2
Yamaguchi, K1
Watanabe, K1
Meyer, M1
Dietzel, H1
Kaetzel, R1
Schmidt, D1
Liebscher, K1
Brennan, SO1
Dubernard, JM1
Anquetil, R1
Brisset, JM1
de Campos-Freire, G1
Cukier, J1
Gelet, A1
Guo, L1
Yamaguchi, Y1
Ikei, S1
Sugita, H1
Ogawa, M1
Rypins, EB1
Milne, N1
Sarfeh, IJ1
Tomizawa, N1
Ohwada, S1
Ohya, T1
Kawashima, Y1
Takeyoshi, I1
Morishita, Y1
Imamura, M1
Mikami, Y1
Takahashi, H1
Yamauchi, H1
Gustafsson, D1
Van Aken, H1
Bode, C1
Darius, H1
Diehm, C1
Encke, A1
Gulba, DC1
Haas, S1
Hacke, W1
Puhl, W1
Quante, M1
Riess, H1
Scharf, R1
Schellong, S1
Schrör, T1
Schulte, KL1
Tebbe, U1
Fiessinger, JN1
Ahnfelt, L1
Björkström, S1
Sjöstedt, A1
Folestad, A1
Arfwidsson, AC1
Elvander, CS1
Smith, JE1
Ruggeri, ZM1
Mannucci, PM1
Allain, JP1
Frommel, D1
Suzuki, M1
Sugitani, M1
Imaki, K1
Toda, M1
Miyamoto, T1
Hahn, RG1
Come, SE1
Shohet, SB1
Robinson, SH1
Breckenridge, RT1
Ratnoff, OD1
Mazur, A1
Peterson, CA1
Borucki, DT1
Austin, G1
Desmond, J1
Borsook, H1
Ratner, K1
Tattrie, B1
Teigler, D1
Lajtha, LG1
Sardesai, VM1
Park, H1
Orten, JM1
Nagai, K1
Kakishita, E1
Shanbrom, E1
Thelin, GM1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
In-office Hysteroscopic Laser Ablation for Symptomatic Submucous Uterine Fibroids: Impact on Size and Vascularization.[NCT05604001]20 participants (Actual)Interventional2018-01-01Completed
Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population[NCT05317806]Phase 415 participants (Anticipated)Interventional2022-10-10Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for glycine and Hemorrhage

ArticleYear
Surgical techniques and outcome in the management of submucous fibroids.
    Current opinion in obstetrics & gynecology, 2013, Volume: 25, Issue:4

    Topics: Embolism; Female; Fertility; Glycine; Gynecology; Hemorrhage; Humans; Hysteroscopy; Leiomyoma; Pregn

2013
Recombinant factor VIIa as an antidote for anticoagulant treatment.
    Seminars in hematology, 2004, Volume: 41, Issue:1 Suppl 1

    Topics: Anticoagulants; Azetidines; Benzylamines; Factor VII; Factor VIIa; Glycine; Helminth Proteins; Hemor

2004
Anticoagulation: the present and future.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2001, Volume: 7, Issue:3

    Topics: Administration, Oral; Amino Acid Chloromethyl Ketones; Anticoagulants; Arginine; Azetidines; Benzyla

2001
[Treatment of deep vein thrombosis. Current and future questions].
    Bulletin de l'Academie nationale de medecine, 2001, Volume: 185, Issue:8

    Topics: Administration, Oral; Anticoagulants; Azetidines; Benzylamines; Glycine; Hemorrhage; Heparin, Low-Mo

2001
Therapy of hereditary disorders of blood coagulation.
    Modern treatment, 1968, Volume: 5, Issue:1

    Topics: Abdomen, Acute; Afibrinogenemia; Blood Coagulation Disorders; Blood Transfusion; Cerebral Hemorrhage

1968

Trials

5 trials available for glycine and Hemorrhage

ArticleYear
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.
    Thrombosis and haemostasis, 2003, Volume: 89, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip

2003
Pharmacokinetics and anticoagulant effect of the direct thrombin inhibitor melagatran following subcutaneous administration to healthy young men.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:7

    Topics: Adult; Anticoagulants; Area Under Curve; Azetidines; Benzylamines; Biological Availability; Blood Co

2003
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replac

2003
Analysis of nutrient hepatic blood flow after 8-mm versus 16-mm portacaval H-grafts in a prospective randomized trial.
    American journal of surgery, 1995, Volume: 169, Issue:2

    Topics: Aniline Compounds; Follow-Up Studies; Glycine; Hemorrhage; Hepatic Encephalopathy; Humans; Imino Aci

1995
Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies.
    Thrombosis research, 2002, Mar-01, Volume: 105, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacemen

2002

Other Studies

36 other studies available for glycine and Hemorrhage

ArticleYear
A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
    Advanced healthcare materials, 2022, Volume: 11, Issue:19

    Topics: Animals; Arginine; Aspartic Acid; Chitosan; Fibrinogen; Fibrinolytic Agents; Glycine; Hemorrhage; He

2022
Glyphosate and Polyoxyethyleneamine Ingestion Leading to Renal, Hepatic, and Pulmonary Failure.
    The American journal of forensic medicine and pathology, 2021, Sep-01, Volume: 42, Issue:3

    Topics: Acute Kidney Injury; Adult; Edema; Glycine; Glyphosate; Hemorrhage; Herbicides; Humans; Liver; Liver

2021
Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.
    Biochemistry, 2015, Jun-23, Volume: 54, Issue:24

    Topics: Amino Acid Substitution; Cysteine Endopeptidases; Enzyme Activation; Enzyme Precursors; Factor IX; F

2015
Mutation in a highly conserved glycine residue in strand 5B of plasminogen activator inhibitor 1 causes polymerisation.
    Thrombosis and haemostasis, 2017, 05-03, Volume: 117, Issue:5

    Topics: Aged; Amino Acid Substitution; Animals; Arginine; Chlorocebus aethiops; Conserved Sequence; COS Cell

2017
Acute lung injury with alveolar hemorrhage due to a novel swine-origin influenza A (H1N1) virus.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:5

    Topics: Acute Lung Injury; Adult; Antiviral Agents; Female; Glycine; Hemorrhage; Humans; Influenza A Virus,

2010
Pathological and toxicological findings in glyphosate-surfactant herbicide fatality: a case report.
    The American journal of forensic medicine and pathology, 2012, Volume: 33, Issue:3

    Topics: Adult; Brain; Brain Edema; Chromatography, High Pressure Liquid; Esophagus; Female; Forensic Patholo

2012
The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:3

    Topics: Animals; Arteries; Azetidines; Benzylamines; Dose-Response Relationship, Drug; Fibrin; Fibrinolytic

2003
[Clinical tests of a new synthetic oxytocin].
    Minerva ginecologica, 1954, Feb-15, Volume: 6, Issue:3

    Topics: Female; Glycine; Hemorrhage; Humans; Obstetric Labor Complications; Oxytocin; Pregnancy

1954
The effect of glycylglycine on the buffer capacity of the blood after hemorrhage; studies with rabbits.
    Annales chirurgiae et gynaecologiae Fenniae. Supplementum, 1954, Volume: 43, Issue:5

    Topics: Acid-Base Equilibrium; Animals; Blood; Buffers; Glycine; Glycylglycine; Hemorrhage; Lagomorpha; Rabb

1954
Betaine and methionine on renal hemorrhagic degeneration in rats receiving 2-amino-2-methyl propanol-1.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1955, Volume: 89, Issue:3

    Topics: Amino Alcohols; Animals; Betaine; Choline; Glycine; Hemorrhage; Kidney; Kidney Diseases; Methionine;

1955
The effect of haemorrhage on the incorporation of [alpha-14C]Glycine into stercobilin.
    The Biochemical journal, 1959, Volume: 71, Issue:1

    Topics: Bile Pigments; Fabaceae; Glycine; Hemorrhage; Humans

1959
[ON THE EFFECTS OF ALPHA-THIOLACTOYLGLYCIN NA ON LOCAL PATHOLOGICAL CHANGES INDUCED BY HEMORRHAGIC SNAKE VENOMS OF TRIMERESURUS FLAVOVIRIDIS, TRIMERESURUS ELEGANS, TRIMERESURUS OKINAVENSIS AND AGKISTRODON BLOMOHOFFII].
    Kita Kanto igaku. Kitakanto medical journal, 1963, Volume: 13

    Topics: Agkistrodon; Animals; Crotalid Venoms; Glycine; Hemorrhage; Injections, Intramuscular; Mice; Necrosi

1963
[Clinical study of a new synthetic oxytocic drug in obstetrics].
    Minerva ginecologica, 1955, Mar-15, Volume: 7, Issue:5

    Topics: Biomedical Research; Female; Glycine; Hemorrhage; Humans; Labor, Obstetric; Obstetrics; Oxytocics; O

1955
Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:10

    Topics: Bleeding Time; Blood Platelets; Blood Proteins; Cell Line; Child, Preschool; Dose-Response Relations

2003
Elastase inhibition reduced death associated with acid aspiration-induced lung injury in hamsters.
    European journal of pharmacology, 2004, Mar-19, Volume: 488, Issue:1-3

    Topics: Animals; Bronchoalveolar Lavage Fluid; Cricetinae; Dose-Response Relationship, Drug; Enzyme Inhibito

2004
Sivelestat, a specific neutrophil elastase inhibitor, prevented phorbol myristate acetate-induced acute lung injury in conscious rabbits.
    Pulmonary pharmacology & therapeutics, 2005, Volume: 18, Issue:4

    Topics: Acute Disease; Animals; Body Weight; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug;

2005
The effects of ximelagatran and warfarin on the prophylaxis of a caval vein thrombosis and bleeding in the anaesthetized rat.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2005, Volume: 16, Issue:4

    Topics: Animals; Azetidines; Benzylamines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Ev

2005
Anteroventral third ventricular N-methyl-D-aspartate receptors, but not metabotropic glutamate receptors are involved in hemorrhagic AVP secretion.
    Brain research bulletin, 2005, Jul-15, Volume: 66, Issue:1

    Topics: Analysis of Variance; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Dizocilpine Maleate; D

2005
Fibrinogen Leipzig II (gamma351Gly-->Ser and gamma82Ala-->Gly): hypodysfibrinogenaemia due to two independent amino acid substitutions within the same polypeptide chain.
    Thrombosis and haemostasis, 2007, Volume: 98, Issue:4

    Topics: Adult; Afibrinogenemia; Alanine; Fibrinogen; Glycine; Haplotypes; Hemorrhage; Heterozygote; Humans;

2007
[Endourethral resection of prostatic adenoma].
    Journal d'urologie, 1983, Volume: 89, Issue:10

    Topics: Anti-Bacterial Agents; Drainage; Endoscopy; Glycine; Hemorrhage; Humans; Male; Prostatectomy; Prosta

1983
Neutrophil elastase inhibitor (ONO-5046) prevents lung hemorrhage induced by lipopolysaccharide in rat model of cerulein pancreatitis.
    Digestive diseases and sciences, 1995, Volume: 40, Issue:10

    Topics: Animals; Ceruletide; Disease Models, Animal; Drug Evaluation, Preclinical; Glycine; Hemorrhage; Leuk

1995
The effect of neutrophil elastase inhibitor in hepatectomy with ischemia in dogs.
    The Journal of surgical research, 1999, Volume: 81, Issue:2

    Topics: Alanine Transaminase; Animals; Biomarkers; Dogs; Endothelium, Vascular; Glycine; Hemorrhage; Hepatec

1999
Effect of a specific synthetic inhibitor of neutrophil elastase (ONO-5046) on the course of acute hemorrhagic pancreatitis in dogs.
    Journal of hepato-biliary-pancreatic surgery, 1998, Volume: 5, Issue:4

    Topics: alpha-Macroglobulins; Amylases; Animals; Blood Pressure; Calcium; Disease Models, Animal; Dogs; Glyc

1998
Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits.
    Thrombosis research, 2001, Feb-01, Volume: 101, Issue:3

    Topics: Animals; Anticoagulants; Azetidines; Benzylamines; Bleeding Time; Blood Coagulation Factors; Factor

2001
Elevated erythrocyte glutathione associated with elevated substrate in high- and low-glutathione sheep.
    Biochimica et biophysica acta, 1977, Feb-28, Volume: 496, Issue:2

    Topics: Adenosine Triphosphate; Animals; Erythrocytes; Glutamate-Cysteine Ligase; Glutamates; Glutathione; G

1977
Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors.
    Annals of the New York Academy of Sciences, 1975, Jan-20, Volume: 240

    Topics: Adolescent; Adult; Antibodies; Antibody Formation; Blood Platelets; Child; Child, Preschool; Cycloph

1975
ONO-5046, a novel inhibitor of human neutrophil elastase.
    Biochemical and biophysical research communications, 1991, Jun-14, Volume: 177, Issue:2

    Topics: Animals; Binding, Competitive; Capillary Permeability; Cricetinae; Glycine; Guinea Pigs; Hemorrhage;

1991
Influence of the fluid balance on the cortisol and glucose responses to transurethral prostatic surgery.
    Acta anaesthesiologica Scandinavica, 1989, Volume: 33, Issue:8

    Topics: Absorption; Aged; Anesthesia, Epidural; Blood Glucose; Blood Pressure; Central Venous Pressure; Glyc

1989
Surface remodelling of reticulocytes produced in response to erythroid stress.
    Nature: New biology, 1972, Apr-05, Volume: 236, Issue:66

    Topics: Animals; Blood Transfusion; Carbon Isotopes; Cell Membrane; Chromatography, Thin Layer; Erythrocytes

1972
Role of the spleen in iron metabolism.
    Annals of the New York Academy of Sciences, 1969, Nov-20, Volume: 165, Issue:1

    Topics: Animals; Bone Marrow; Carbon Isotopes; Cobalt; Enzymes; Erythrocytes; Erythropoietin; Glycine; Heme;

1969
Pre-assayed AHF concentrate therapy for hemophilia.
    Bibliotheca haematologica, 1968, Volume: 29

    Topics: Adolescent; Adult; Antibodies; Blood Transfusion; Chemical Precipitation; Child, Preschool; Cold Tem

1968
Complications of transurethral prostatic surgery.
    Canadian Anaesthetists' Society journal, 1970, Volume: 17, Issue:1

    Topics: Age Factors; Aged; Burns, Electric; Cardiovascular Diseases; Glycine; Hemorrhage; Humans; Male; Midd

1970
Erythropoietin and the development of erythrocytes. Effect of erythropoietin in vitro which simulates that of a massive dose in vivo.
    Nature, 1968, Mar-16, Volume: 217, Issue:5133

    Topics: Aging; Animals; Bone Marrow Cells; Carbon Isotopes; Cell Differentiation; Cytoplasm; Dactinomycin; E

1968
A comparison of porphyrin synthesis in certain tissues from normal and anemic dogs: some observations on the in vivo control of porphyrinogenesis.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1968, Volume: 127, Issue:4

    Topics: Acetates; Amino Acids; Anemia; Animals; Dogs; Erythropoietin; Glycine; Hemorrhage; Iron; Kidney; Lev

1968
Destruction of immature erythrocytes measured by bilirubin excretion.
    Blood, 1969, Volume: 33, Issue:5

    Topics: Animals; Biliary Fistula; Bilirubin; Carbon Isotopes; Erythrocytes; Erythropoiesis; Glycine; Hemorrh

1969
Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
    JAMA, 1969, Jun-09, Volume: 208, Issue:10

    Topics: Acute Disease; Adult; Blood Pressure; Chemical Precipitation; Factor VIII; Fibrinogen; Glycine; Hemo

1969